Improved detection of advanced oxidation protein products in plasma

被引:205
|
作者
Hanasand, Marita [1 ,2 ]
Omdal, Roald [2 ,3 ]
Norheim, Katrine B. [2 ]
Goransson, Lasse G. [2 ,3 ]
Brede, Cato [1 ]
Jonsson, Grete [1 ]
机构
[1] Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway
[2] Stavanger Univ Hosp, Dept Internal Med, Clin Immunol Unit, N-4068 Stavanger, Norway
[3] Univ Bergen, Inst Internal Med, N-5020 Bergen, Norway
关键词
Advanced oxidation protein products; Protein oxidation; Lipoprotein solubility; Spectrophotometry; Method validation; Chronic inflammation; FREE-RADICALS; STRESS; MYELOPEROXIDASE; ANTIOXIDANTS; BIOMARKERS; MARKER; DAMAGE; ASSAY;
D O I
10.1016/j.cca.2012.01.038
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Oxidative stress has been associated with many diseases and can among others be assessed as increased levels of advanced oxidation protein products (AOPP). Current AOPP methods suffer from poor reproducibility and accuracy due to precipitation of lipids in plasma samples. We therefore aimed to develop a robust method in which plasma lipids are solubilized. Methods: Plasma was diluted with citric acid, and AOPP measured as absorbance at 340 nm. The method was optimized and validated, and then used to analyze AOPP levels in plasma from healthy control subjects (HC), and in three patients groups; chronic kidney disease (CKD), primary Sjogren's Syndrome (pSS) and systemic lupus erythematosus (SLE). Results: AOPP was detected with improved precision compared to established methods where lipids precipitate. Within- and between days variations were less than 1.4% and 22%, respectively. A control chart was established and the long-term reproducibility followed over six months. Conclusions: This improved method detects plasma AOPP with significantly better reproducibility and accuracy compared to previously reported methods. Solubilization of plasma lipids before spectrophotometric measure of AOPP levels is novel. It prevents both loss of lipoproteins due to precipitation and overestimation as a result of light scattering. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 50 条
  • [31] Advanced oxidation protein products (AOPPs) accelerate bone loss in rats
    Zheng, Shuai
    Qin, Shuai
    Zhong, Zhao-Ming
    Wu, Qian
    Ding, Ruo-Ting
    Liao, Cong-Rui
    Chen, Jian-Ting
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11289 - 11300
  • [32] Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis
    Alagozlu, Hakan
    Gorgul, Ahmet
    Bilgihan, Ayse
    Tuncer, Candan
    Unal, Selahattin
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (01) : 80 - 85
  • [33] Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics
    Matteucci, E
    Biasci, E
    Giampietro, O
    ACTA DIABETOLOGICA, 2001, 38 (04) : 187 - 189
  • [34] Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores
    Seyed Reza Najafizadeh
    Khatereh Amiri
    Maryam Moghaddassi
    Shaghayegh Khanmohammadi
    Hossein Mirmiranpour
    Manouchehr Nakhjavani
    Clinical Rheumatology, 2021, 40 : 4019 - 4026
  • [35] Are advanced oxidation protein products potential uremic toxins?
    Witko-Sarsat, V
    Gausson, V
    Descamps-Latscha, B
    KIDNEY INTERNATIONAL, 2003, 63 : S11 - S14
  • [36] The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis
    Hanxiao Ou
    Zhuping Huang
    Zhongcheng Mo
    Ji Xiao
    Cardiovascular Toxicology, 2017, 17 : 1 - 12
  • [37] The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis
    Ou, Hanxiao
    Huang, Zhuping
    Mo, Zhongcheng
    Xiao, Ji
    CARDIOVASCULAR TOXICOLOGY, 2017, 17 (01) : 1 - 12
  • [38] Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease
    Altunoglu, Esma
    Guntas, Gulcan
    Erdenen, Fusun
    Akkaya, Esen
    Topac, Ibrahim
    Irmak, Hulya
    Derici, Himmet
    Yavuzer, Hakan
    Gelisgen, Remise
    Uzun, Hafize
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2015, 15 (07) : 872 - 880
  • [39] Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria
    Liang, Min
    Wang, Jun
    Xie, Chao
    Yang, Yan
    Tian, Jian Wei
    Xue, Yao Ming
    Hou, Fan Fan
    JOURNAL OF DIABETES, 2014, 6 (05) : 417 - 426
  • [40] Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis
    Wu, Qian
    Zhong, Zhao-Ming
    Pan, Ying
    Zeng, Ji-Huan
    Zheng, Shuai
    Zhu, Si-Yuan
    Chen, Jian-Ting
    MEDICAL SCIENCE MONITOR, 2015, 21